Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | CA1 | P00915 | 6/20 | 0.64 |
| ▸ | CA2 | P00918 | 6/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | GRK6 | P43250 | 2/20 | 0.54 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.48 |
| ▸ | PYGB | P11216 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6672229 | 1.00 | TSHR (0.70) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL13995569 | 0.86 | TSHR (0.55) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL13995568 | 0.86 | TSHR (0.55) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL13680075 | 0.84 | CA1 (0.68) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL6686920 | 0.84 | TSHR (0.66) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL6675392 | 0.84 | TSHR (0.66) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL2573470 | 0.84 | NPC1 (0.76) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL14353200 | 0.84 | NPC1 (0.76) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL2573474 | 0.84 | NPC1 (0.76) | TSHRCA1CA2NPC1RAB9A | |
| SCHEMBL14478652 | 0.84 | NPC1 (0.76) | TSHRCA1CA2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12129233-B2 | Water-soluble salts of cannabinoids, preparation and uses thereof | Aurora Fine Chemicals LLC (US) | 2024-10-29 | — | — | US | disclosed |
| US-20220332694-A1 | New water-soluble salts of cannabinoids, preparation and uses thereof | Aurora Fine Chemicals LLC (US) | 2022-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12129233-B2 | Water-soluble salts of cannabinoids, preparation and uses thereof | CNR1, CNR2, FAAH | TSHR 3964/4885CA1 3457/4885CA2 3128/4885 |
| US-20220332694-A1 | New water-soluble salts of cannabinoids, preparation and uses thereof | CNR1, CNR2, GPR18 | TSHR 3718/4885CA1 3196/4885CA2 2938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.